AI-Powered Genetic Diagnostics
CLIA Certified Lab

AI-Powered Healthcare ThroughPredictive Genetics& Precision Medicine

Comprehensive hereditary cancer genetic testing & risk assessment — BRCA1/BRCA2 screening, Lynch syndrome detection & 108-gene panels

  • Precision Oncology — the most comprehensive hereditary cancer screen available

  • Inherited cancer risk — identify genetic variants linked to breast, ovarian, colon & more

  • BRCA & multi-gene testing — full BRCA1/BRCA2 analysis alongside 106 additional genes

  • Clinical insight — actionable reports designed for patients and healthcare providers

10+
Genetic Tests
99.9%
Accuracy
2000+
Genes Analyzed
Executive Summary

The Future of Precision Medicine
Is Already Here

Gene Matrix AI delivers AI-powered genetic diagnostics across four strategic pillars — shifting global healthcare from reactive treatment to predictive, preventive, and personalized genomic medicine.

Global Precision Genomics Market:$15.49B (2024)$17.66B (2025)↑ 14.8% CAGR
AI-Powered

Predictive

99.9%Diagnostic Accuracy
  • Analyzes 2,000+ genetic markers per patient
  • AI trained on 50M+ genomic sequences
  • Detects risk up to 15 years before symptoms
  • NGS technology — 32.67% of global market

Precision genomics market: $15.49B in 2024 → $17.66B by 2025

Cost-Saving

Preventive

3:1ROI Within 6 Months
  • $136B in adverse drug events prevented annually
  • 60% reduction in rare disease diagnostic odysseys
  • 20% ROI for corporate wellness programs
  • Genome sequencing cost dropped to ~$600 in 2024

Preventive genomics reduces hospital costs by up to 60% per patient

PGx Certified

Personalized

89%Patient Willingness for PGx
  • 75% of drug side effects linked to 3 key genes
  • 60% of patients prescribed actionable PGx drugs
  • FDA approved 18 personalized medicines in 2024
  • Pharmacogenomics market CAGR: 8.5–10.6% to 2034

Personalized medicine market valued at $567.1B globally in 2024

Franchisable

Global

20.28%Asia-Pacific CAGR 2025–2030
  • North America holds 42.92% of global market share
  • Asia-Pacific fastest-growing region worldwide
  • Deployable across all healthcare systems globally
  • CLIA, HIPAA, ISO 15189 & CAP certified platform

Global precision genomics CAGR: 11.6–14.8% through 2030

From Sample to Insight

Our 4-Step Genomic Process

01Sample Collection
02Sequencing
03AI Analysis
04Clinical Report
Results delivered in under 72 hours from sample receipt
CLIA Certified · HIPAA Compliant · ISO 15189 · CAP Accredited
Genome Seq. Cost
~$600
Down from $3B in 2003
PGx Market CAGR
10.6%
Through 2034
FDA Approvals 2024
18
Personalized medicines
ADR Cost (US)
$136B
Preventable annually
Oncology Share
40.2%
Of personalized medicine
APAC Growth
20.28%
CAGR 2025–2030

Sources: Grand View Research · SNS Insider · NIH · FDA · Market.us · GlobalRPH — 2024/2025 Data

Critical Data

The Global Healthcare Crisis

The numbers reveal an urgent need for genomic-driven transformation

$1.4T
Annual Cost

Spent yearly on treating avoidable chronic diseases

45%
Drug Reactions

Of patients suffer adverse drug reactions — 1M hospitalizations annually

3x
Late Detection

More cost for delayed cancer diagnoses vs early detection

$1T
Productivity Lost

Lost globally due to mental health misdiagnosis each year

Gene Matrix AI is changing this
Comprehensive Testing Suite

Gene Matrix Product Portfolio

Precision genomics solutions powered by AI for every healthcare need. Discover our comprehensive range of genetic testing services — from hereditary cancer screening to pharmacogenomics.

7+

Test Categories

1000+

Genes Analyzed

99%+

Accuracy Rate

48hr

Fastest Results

Ready to Unlock Your Genetic Insights?

Explore our complete range of genetic tests and find the perfect solution for your healthcare needs.

Pricing Plans

Choose YourHealth Journey

Unlock the power of your DNA with our comprehensive genetic testing subscriptions

MonthlyAnnualSave 20%

Essential

$125 one-time kit fee

$69/month
Save 71% vs individual tests
  • 2 Genetic tests per year
  • Annual 108-gene cancer screening
  • 77+ cancer screening types
  • Basic AI-powered reports
  • Mobile app access
  • Email support
Most Popular

Premium

$125 one-time kit fee

$89/month
Save 84% vs individual tests
  • Everything in Essential +
  • 4 genetic tests per year
  • Bi-annual 188-gene screening
  • Gene Mind mental health panel
  • Advanced AI analytics
  • Priority 48-hour processing
  • Genetic counselor session
  • Family health insights

Family

$125 one-time kit fee

$139/month
Save 93% vs individual tests
  • Everything in Premium +
  • Coverage for up to 4 people
  • Bi-annual screening for all
  • Gene Baby pediatric panels
  • Family genetic risk mapping
  • Shared family dashboard
  • Dedicated account manager
  • Privacy controls per member
For Organizations

EnterpriseCustom Solutions

$299/month

+ $75 per employee kit fee

Volume DiscountsROI AnalysisCustom Integration
Unlimited employee testing
Bi-annual 188-gene screening
Corporate wellness dashboard
Custom genetic panels
EHR/wellness integration
Population health analytics
White-label capabilities
Research collaboration
HIPAA Compliant
256-bit Encryption
30-Day Money Back
24/7 Support
Artificial Intelligence Core

Gene Matrix AI Engine

Our proprietary AI processes millions of genomic data points through advanced neural networks, delivering actionable health intelligence with unprecedented precision.

Accuracy Rate
Genes Analyzed
Reports Generated
Avg. Turnaround
Sample Collection
DNA Extraction
Sequencing
AI Analysis
Report Generation
Live App Preview

Inside the GeneMatrix App

Your genomic health dashboard — real-time AI insights, risk analysis, and personalized action plans at your fingertips

9:41

Welcome back

Sarah Mitchell

SM
0

Health Score

+5 from last quarter

2,147 genes analyzed

Gene Risk Markers

View All
BRCA1low
12%
TP53low
8%
APOEmoderate
34%
MTHFRlow
22%
CYP2D6elevated
67%
HFElow
5%

Risk Dashboard

9:41

AI Analysis

Powered by GeneMatrix Engine

Drug Sensitivity

CYP2D6 Variant Detected

Reduced metabolism of codeine, tramadol. Consider alternative analgesics.

Nutrition Profile

MTHFR C677T Heterozygous

Methylfolate supplementation recommended. Optimize B12 intake.

Cardiac Risk

APOE ε3/ε4 Genotype

Moderate cardiovascular predisposition. Lipid panel monitoring advised.

Recommended Actions

Schedule pharmacogenomics consultURGENT
Update medication profile
Review dietary supplements

AI Insights

9:41

Testing Timeline

On Track

Initial Screening

Jan 2025

GenePGx Analysis

Mar 2025

Cancer Panel

Jun 2025

Follow-up Review

Sep 2025

Recent Reports

GeneCancer Panel

Jun 12, 2025 · 48 pages

GenePGx Report

Mar 8, 2025 · 32 pages

Full Screening

Jan 15, 2025 · 64 pages

Health Timeline

HIPAA Encrypted

Military-grade encryption protects your genomic data at every layer

Real-time Sync

Results update instantly as new analyses complete across all devices

Share with Providers

One-tap secure sharing with your healthcare team via encrypted portal

By The Numbers

Trusted by Thousands

Real results from real people. Our platform delivers measurable impact across the globe.

3,300+

Reports Generated

Across 6 continents

1,650+

Samples Processed

Processed monthly

32.5%

Satisfaction Rate

Verified reviews

1

Countries Served

Active regions

Trusted by leading medical institutions

Mayo Clinic
Johns Hopkins
Cleveland Clinic
Stanford Medicine
Harvard Medical
NIH Partner
CLIA Certified
HIPAA Compliant
ISO 15189
CAP Accredited
Real Stories

What Our Clients Say

Real stories from real people who transformed their health

GenePGx
Improved outcomes
"GenePGx gives us the clarity to personalize prescriptions. The difference in patient outcomes is remarkable — I now recommend it to every patient before starting a new treatment."
Dr. Ethan Ramirez

Dr. Ethan Ramirez

Clinical Pharmacologist

San Diego, CA

Verified Patient

10,000+

Lives Transformed

98.5%

Satisfaction Rate

4.9/5

Average Rating

No credit card required • Free consultation • HIPAA compliant

Worldwide Network

Global Presence

Delivering precision genomics across strategic locations with state-of-the-art facilities and expanding into new territories

4
Active Locations
4
Expanding Soon
448M+
Population Reach
24/7
Operations

North Macedonia

Active

North Macedonia

Population

1,836,713

Timeline

Est. 2023

Key Operations

European Genomics Research Lab
Clinical Data Processing Center
Balkan Regional Operations
Location 2 of 8Auto-rotating
Active Locations
🇺🇸

Chicago HQ

United States

Pop: 331,900,000
Est. 2022
🇲🇰

North Macedonia

North Macedonia

Pop: 1,836,713
Est. 2023
🇦🇱

Albania

Albania

Pop: 2,877,797
Est. 2024
🇸🇮

Slovenia

Slovenia

Pop: 2,119,675
Est. 2024
Coming Soon
🇷🇸

Serbia

Serbia

Pop: 6,647,003
Launching Q1 2026
🇦🇿

Azerbaijan

Azerbaijan

Pop: 10,412,651
Launching Q2 2026
🇧🇬

Bulgaria

Bulgaria

Pop: 6,520,314
Launching Q2 2026
🇹🇷

Turkey

Turkey

Pop: 85,279,553
Launching Q2 2026

Our Vision

Transforming the future of precision healthcare

01

Gene Matrix is the missing link between advanced science and scalable care.

02

We are building the bridge from DNA to decisions, from prediction to prevention.

03

Let's bring precision health to every corner of the world — affordably, ethically, and efficiently.

Get in Touch

Ready to transform healthcare together?

Cookie & Privacy Preferences

HIPAA GDPR

We use cookies to ensure our website functions securely and to improve your experience. As a healthcare provider handling sensitive genetic data, we adhere to strict HIPAA and GDPR standards. No personal health information (PHI) is ever stored in cookies. You can customize your preferences below.

Privacy Policy